Mavenir and Terrestar Solutions Partner to Accelerate Commercial Deployment of 5G New Radio Non-Terrestrial Network
23.2.2024 18:49:00 EET | Business Wire | Press release
Mavenir, the cloud-native network infrastructure provider building the future of networks, continues its pioneering leadership in Open RAN with 5G New Radio (NR) Non-Terrestrial-Network (NTN) solutions. The latest initiative is to integrate satellite connectivity for Open RAN terrestrial networks thereby enabling seamless connectivity for users across satellite and terrestrial networks. The project is being delivered in collaboration with Terrestar Solutions, a Canadian based Satellite Operator.
Satellite Operators are actively looking at ways to harness 5G NTN capabilities within their network topology, to extend coverage and capacity in areas where traditional terrestrial networks may be economically unfeasible or impractical. Terrestar will launch a new Narrowband IoT (NB-IoT) service offer to the market, evolving to a full 5G Direct to Device (D2D) service by 2025. As the chosen technology supplier, Mavenir will provide the enabling 3GPP standards-compliant Core and O-RAN interface technology. Open RAN implementations, aligned to the O-RAN alliance specifications, are driving the deployment of open, intelligent, and secure networks for both mobile network and satellite network owners.
Jacques Leduc, President and CEO of Terrestar Solutions, announced, “This partnership aims to develop interoperable standards that seamlessly link multi-orbit satellite systems, ground infrastructure, and mobile devices together. This initiative is a pivotal step towards ensuring every Canadian enjoys seamless, high-quality connectivity, directly benefiting both industries and consumers."
Pardeep Kohli, CEO at Mavenir, said, “Mavenir's O-RAN, built on ETSI O-RAN 3GPP R.17 standards, makes it possible to integrate terrestrial and satellite service points quickly and seamlessly. Working with our partner Terrestar, this project showcases the remarkable flexibility that can be achieved through this standard and technology. Open RAN deployments are demonstrating their clear potential for enabling unprecedented levels of connectivity for consumers and industries, surpassing the possibilities of traditional RAN software builds.”
About Terrestar Solutions
Terrestar Solutions Inc. is a Canadian mobile satellite operator engaged in the race to bring direct-to-device satellite services to smartphones and IoT devices and make anywhere in Canada communication a reality. The Company is committed to nurturing the ever-evolving, standards-based and open network ecosystem, enabling Mobile Network Operators to deliver ubiquitous communication services. Thanks to the Echostar T1 satellite, its ground network infrastructure and mobile satellite spectrum, Terrestar connects Canadians from almost anywhere in the country, even in Canada’s most remote regions through its Strigo Mobile Satellite Service (MSS). The Strigo service also supports non-profit and First Nations organizations, a testament to the Company’s strong sense of responsibility towards the welfare and progress of the communities it serves. For more information, visit www.terrestarsolutions.ca, contact media@terrestarsolutions.ca, or follow us on LinkedIn.
About Mavenir
Mavenir is building the future of networks today with cloud-native, AI-enabled solutions which are green by design, empowering operators to realize the benefits of 5G and achieve intelligent, automated, programmable networks. As the pioneer of Open RAN and a proven industry disruptor, Mavenir’s award-winning solutions are delivering automation and monetization across mobile networks globally, accelerating software network transformation for 300+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers. For more information, please visit www.mavenir.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223235087/en/
Contact information
Terrestar PR Contact:
Victoria Ollers
Terrestar Solutions
vicki.ollers@terrestar.ca
Mavenir PR Contact:
Emmanuela Spiteri
pr@mavenir.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom